Abstract
Activating mutations in members of the RAS family of genes are among the most common genetic events in human tumorigenesis. Once thought to be functionally interchangeable, it is increasingly recognized that the classical members of this protein family (H-RAS, N-RAS and K-RAS4B) exhibit unique and shared functions that are highly context-dependent. Herein, we demonstrate that the presence of an oncogenic KRAS allele results in elevated levels of GTP-bound N-RAS (N-RASĀ·GTP) in two human colorectal cancer cell lines, HCT 116 and DLD-1, compared to their isogenic counterparts in which the mutant KRAS allele has been disrupted by homologous recombination. N-RAS subserves an antiapoptotic role in cells expressing wild-type K-RAS; this function is compromised, however, by the presence of mutant K-RAS, and these cells display increased sensitivity to apoptotic stimuli. We additionally identify a physical interaction between N-RAS and gelsolin, a factor that has been shown to promote survival and show that the N-RAS:gelsolin complex is modulated differently in wild-type and mutant K-RAS environments following apoptotic challenge. These findings represent the first biochemical evidence of a functional relationship between endogenous RAS proteins and identify a dynamic physical interaction between endogenous N-RAS and gelsolin that correlates with survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Apolloni A, Prior IA, Lindsay M, Parton RG, Hancock JF . (2000). H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol 20: 2475ā2487.
Archer SY, Hodin A . (1999). Histone acetylation and cancer. Curr Opin Genet Dev 9: 171ā174.
Bos JL . (1989). ras oncogenes in human cancer: a review. Cancer Res 49: 4682ā4689.
Cantrell DA, Davies AA, Crumpton MJ . (1985). Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. Proc Natl Acad Sci USA 82: 8158ā8162.
Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H et al. (2002). Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 4: 343ā350.
Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D et al. (1999). Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98: 69ā80.
Diaz R, Ahn D, Lopez-Barcons L, Malumbres M, Perez de Castro I, Lue J et al. (2002). The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res 62: 4514ā4518.
Downward J . (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3: 11ā22.
Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA . (1990). Stimulation of p21 ras upon T-cell activation. Nature 346: 719ā723.
Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Medarde A, Swaminathan N, Yienger K et al. (2001). Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 21: 1444ā1452.
Hamilton M, Wolfman A . (1998). Ha-ras and N-ras regulate MAPK activity by distinct mechanisms in vivo. Oncogene 16: 1417ā1428.
Hamilton M, Liao J, Cathcart MK, Wolfman A . (2001). Constitutive association of c-N-Ras with c-Raf-1 and protein kinase C epsilon in latent signaling modules. J Biol Chem 276: 29079ā29090.
Hancock JF . (2003). Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 4: 373ā384.
Hancock JF, Cadwallader K, Paterson H, Marshall CJ . (1991). A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J 10: 4033ā4039.
Hancock JF, Magee AI, Childs JE, Marshall CJ . (1989). All ras proteins are isoprenylated but only some are palmitoylated. Cell 57: 1167ā1177.
Hancock JF, Paterson H, Marshall CJ . (1990). A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21 ras to the plasma membrane. Cell 63: 133ā139.
Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E et al. (1997). K-ras is an essential gene in the mouse with partial functional overlap with N-Ras. Genes Dev 11: 2468ā2481.
Klampfer L, Huang J, Sasazuki T, Shirasawa S, Augenlicht L . (2004). Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression. J Biol Chem 279: 36680ā36688.
Klampfer L, Swaby LA, Huang J, Sasazuki T, Shirasawa S, Augenlicht L . (2005). Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis. Oncogene 24: 3932ā3941.
Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, Hatta T et al. (1997). K-ras is essential for the development of the mouse embryo. Oncogene 15: 1151ā1159.
Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K et al. (1997). Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294ā298.
Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M, Tsujimoto Y et al. (2000). Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J Biol Chem 275: 15343ā15349.
Kusano H, Shimizu S, Koya RC, Fujita H, Kamada S, Kuzumaki N et al. (2000). Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 19: 4807ā4814.
Matallanas D, Sanz-Moreno V, Arozarena I, Calvo F, Agudo-Ibanez L, Santos E et al. (2006). Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol Cell Biol 26: 100ā116.
Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S et al. (1997). Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J 16: 4650ā4656.
Prior IA, Hancock JF . (2001). Compartmentalization of Ras proteins. J Cell Sci 114: 1603ā1608.
Prior IA, Muncke C, Parton RG, Hancock JF . (2003). Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 160: 165ā170.
Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M et al. (2005). An acylation regulates localization and activity of palmitoylated Ras isoforms. Science 307: 1746ā1752.
Roy S, Luetterforst R, Harding A, Apolloni A, Etheridge M, Stang E et al. (1999). Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domain. Nat Cell Biol 1: 98ā105.
Roy S, Plowman S, Rotblat B, Prior IA, Muncke C, Grainger S et al. (2005). Individual palmitoyl residues serve distinct roles in h-ras trafficking, microlocalization, and signaling. Mol Cell Biol 25: 6722ā6733.
Shirasawa S, Furuse M, Yokoyama N, Sasazuki T . (1993). Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85ā88.
Umanoff H, Edelmann W, Pellicer A, Kucherlapati R . (1995). The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA 92: 1709ā1713.
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M et al. (1988). Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525ā532.
White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M et al. (1995). Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533ā541.
Whitehead RH, Brown A, Bhathal PS . (1987). A method for the isolation and culture of human colonic crypts in collagen gels. In vitro Cell Dev Biol 23: 436ā442.
Willumsen BM, Christensen A, Hubbert NL, Papageorge AG, Lowy DR . (1984). The p21 ras C-terminus is required for transformation and membrane association. Nature 310: 583ā586.
Wolfman JC, Wolfman A . (2000). Endogenous c-N-Ras provides a steady-state anti-apoptotic signal. J Biol Chem 275: 19315ā19323.
Wolfman JC, Palmby T, Der CJ, Wolfman A . (2002). Cellular N-Ras promotes survival by downregulation of Jun N-terminal protein kinase and p38. Mol Cell Biol 22: 1589ā1606.
Yin HL, Stossel TP . (1979). Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatorty protein. Nature 281: 583ā586.
Acknowledgements
RJC acknowledges the support of NCI P50 95103 Special Program of Research Excellence (SPORE), U01 084239 Mouse Models of Human Cancers Consortium (MMHCC) and R01 CA46413.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keller, J., Haigis, K., Franklin, J. et al. Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS: gelsolin complex. Oncogene 26, 3051ā3059 (2007). https://doi.org/10.1038/sj.onc.1210103
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210103
Keywords
This article is cited by
-
RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
Oncogene (2013)
-
Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells
Journal of Molecular Medicine (2012)
-
Non-Redundancy within the RAS Oncogene Family: Insights into Mutational Disparities in Cancer
Molecules and Cells (2009)
-
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
Nature Genetics (2008)